Please login to the form below

Not currently logged in
Email:
Password:

Pharmalink appoints new chairman Anders Wiklund

The Swedish specialty pharma company has also appointed Elisabeth Lindner to its board of directors

Anders Wiklund has joined Swedish specialty pharma company Pharmalink AB as chairman of the board.

He previously spent 29 years with the Kabi and Pharmacia group of companies, holding roles such as UK managing director of KabiVitrum, president of KabiVitrum International in Sweden, president and CEO of KabiVitrum and KabiPharmacia in the US.

In his new role Wiklund, who currently serves on the boards of QuatRX, EffRx, Clavis Pharma and Life Medical, will take over from Pharmalink's outgoing chairman Bengt Julander.

Julander, who founded the company in 1991, will remain on Pharmalink's board as a non-executive director, as will Lennart Hansson.

In Hansson's place on the board of directors Pharmalink has appointed Elisabeth Lindner, who joins from fellow Swedish pharmaceutical company Diamyd Medical AB.

"With Anders taking on the Chairman's role and Elisabeth joining the Board, Pharmalink is positioned for the next stage of development," said Johan Haggblad, managing director of Pharmalink.

"Anders' and Elisabeth's exceptional industry experience will be invaluable in ensuring we realise value for Pharmalink and for patients with significant unmet medical need."

15th November 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

ema1
The European Medicines Agency: PRIME’d for access?
Leela Barham examines the impact of the EMA's PRIME fast track system after two years...
How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...

Infographics